Previous close | 23.97 |
Open | 24.37 |
Bid | 23.69 x 100 |
Ask | 23.98 x 200 |
Day's range | 23.80 - 25.40 |
52-week range | 9.44 - 36.25 |
Volume | |
Avg. volume | 601,244 |
Market cap | 1.234B |
Beta (5Y monthly) | 2.93 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
4D Molecular Therapeutics ( NASDAQ:FDMT ) First Quarter 2024 Results Key Financial Results Revenue: US$28.0k (down 91...
Comprehensive Analysis of First Quarter Financials and Strategic Developments